AlphaStocks
4.7
Weak

Idexx Laboratories Inc (IDXX)

As of Sep 20, 2026, Idexx Laboratories Inc (IDXX) scores 4.7/10 on AlphaStocks' five-model composite, #122 of 168 Health Care stocks. At $511, IDXX trades 40% above its model fair value of $365.

Health Care / Health Care Equipment

S&P 500

$511.48

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#122out of 168 in Health Care

Is IDEXX LABORATORIES INC /DE a Good Investment in 2026?

IDEXX LABORATORIES INC /DE (IDXX) scores 4.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates IDEXX LABORATORIES INC /DE as Strong (8/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 3.0% · ROC >100%. IDEXX LABORATORIES INC /DE currently trades 40% above its estimated fair value of $365. IDEXX LABORATORIES INC /DE ranks #122 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E39.1ROE-16.5Market Cap41B

Estimated Fair Value

$364.6540% above

Trading above estimated fair value. P/e of 39x implies high growth expectations.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

PEG 3.7 · Stalwart

Greenblatt

Caution

Earnings yield 3.0% · ROC >100%

Frequently Asked Questions

Is IDEXX LABORATORIES INC /DE (IDXX) a good investment?
As of Sep 20, 2026, Idexx Laboratories Inc (IDXX) scores 4.7/10 on AlphaStocks' five-model composite, #122 of 168 Health Care stocks. At $511, IDXX trades 40% above its model fair value of $365. That score is below average, suggesting caution.
What is IDEXX LABORATORIES INC /DE's Piotroski F-Score?
IDEXX LABORATORIES INC /DE's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is IDXX overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $365, IDXX appears overvalued. The stock currently trades 40% above its estimated fair value. Trading above estimated fair value. P/e of 39x implies high growth expectations.
How does IDXX compare to other Health Care stocks?
IDEXX LABORATORIES INC /DE ranks #122 out of 168 stocks in the Health Care sector, placing it in the top 73% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about IDXX?
AlphaStocks evaluates IDXX using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.7/10.

Similar Stocks

INSPUFPTBDX

Compare IDXX with

IDXX vs INSPIDXX vs UFPTBDX vs IDXXIDXX vs PARRFTI vs IDXXIDXX vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer